← Back to headlines
Johnson & Johnson Benefits from Strong Growth Pipeline and Key Therapeutic Areas
Johnson & Johnson (JNJ) is experiencing positive performance, driven by its robust growth pipeline and strong presence across several key therapeutic areas.
31 Mar, 16:05 — 31 Mar, 16:05
Sources
Showing 1 of 1 sources
Related Stories
Toxic Smoke from Navotas Landfill Fire Reaches Bulacan Villages
just now
Financial Barriers Hinder Vaccine Access in Philippines
just now
Polish Employers Consider Time Off for Preventive Health Check-ups
13m ago
German Health Minister's Reform Criticized for Impact on Workers and Unaddressed Savings
20m ago